The DOI matches its Crossref record; 214 of the 214 references it cites were found in a registry or an index.
Biomimetic Nanotechnology toward Personalized Vaccines
Open accessAbstract
While traditional approaches for disease management in the era of modern medicine have saved countless lives and enhanced patient well‐being, it is clear that there is significant room to improve upon the current status quo. For infectious diseases, the steady rise of antibiotic resistance has resulted in super pathogens that do not respond to most approved drugs. In the field of cancer treatment, the idea of a cure‐all silver bullet has long been abandoned. As a result of the challenges facing current treatment and prevention paradigms in the clinic, there is an increasing push for personalized therapeutics, where plans for medical care are established on a patient‐by‐patient basis. Along these lines, vaccines, both against bacteria and tumors, are a clinical modality that could benefit significantly from personalization. Effective vaccination strategies could help to address many challenging disease conditions, but current vaccines are limited by factors such as a lack of potency and antigenic breadth. Recently, researchers have turned toward the use of biomimetic nanotechnology as a means of addressing these hurdles. Recent progress in the development of biomimetic nanovaccines for antibacterial and anticancer applications is discussed, with an emphasis on their potential for personalized medicine.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
Hartkopf, A. D., Taran, F.-A., Wallwiener, M., Walter, C. B., Krämer, B., Grischke, E.-M., & Brucker, S. Y. (2016) · Breast Care · doi:10.1159/000453569 · Cited by 30,845
The blockade of immune checkpoints in cancer immunotherapy
Pardoll, D. M. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3239 · Cited by 13,838
Sørlie, T., Perou, C. M., Tibshirani, R., Aas, T., Geisler, S., Johnsen, H., Hastie, T., Eisen, M. B., van de Rijn, M., Jeffrey, S. S., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.191367098 · Cited by 10,938
The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors
Kawai, T., & Akira, S. (2010) · Nature Immunology · doi:10.1038/ni.1863 · Cited by 9,304
Mosmann, T. R., & Coffman, R. L. (1989) · Annual Review of Immunology · doi:10.1146/annurev.iy.07.040189.001045 · Cited by 7,692
Cancer immunotherapy using checkpoint blockade
Ribas, A., & Wolchok, J. D. (2018) · Science · doi:10.1126/science.aar4060 · Cited by 6,791
PD-1 blockade induces responses by inhibiting adaptive immune resistance
Tumeh, P. C., Harview, C. L., Yearley, J. H., Shintaku, I. P., Taylor, E. J. M., Robert, L., Chmielowski, B., Spasic, M., Henry, G., Ciobanu, V., et al. (2014) · Nature · doi:10.1038/nature13954 · Cited by 6,609
Pushko, P., Pumpens, P., & Grens, E. (2013) · Intervirology · doi:10.1159/000346773 · Cited by 5,950
Neoantigens in cancer immunotherapy
Schumacher, T. N., & Schreiber, R. D. (2015) · Science · doi:10.1126/science.aaa4971 · Cited by 4,783
The pathogenesis of cancer metastasis: the ‘seed and soil’ hypothesis revisited
Fidler, I. J. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1098 · Cited by 4,686
Lichtenstein, P., Holm, N. V., Verkasalo, P. K., Iliadou, A., Kaprio, J., Koskenvuo, M., Pukkala, E., Skytthe, A., & Hemminki, K. (2000) · New England Journal of Medicine · doi:10.1056/nejm200007133430201 · Cited by 4,114
Antibacterial resistance worldwide: causes, challenges and responses
Levy, S. B., & Marshall, B. (2004) · Nature Medicine · doi:10.1038/nm1145 · Cited by 4,052
Tumour heterogeneity and resistance to cancer therapies
Dagogo-Jack, I., & Shaw, A. T. (2018) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2017.166 · Cited by 3,846
Lateral gene transfer and the nature of bacterial innovation
Ochman, H., Lawrence, J. G., & Groisman, E. A. (2000) · Nature · doi:10.1038/35012500 · Cited by 3,816
Pierschbacher, M. D., & Ruoslahti, E. (1984) · Nature · doi:10.1038/309030a0 · Cited by 3,658
The expanding universe of T-cell subsets: Th1, Th2 and more
Mosmann, T. R., & Sad, S. (1996) · Immunology Today · doi:10.1016/0167-5699(96)80606-2 · Cited by 3,633
Immunogenic cell death and DAMPs in cancer therapy
Krysko, D. V., Garg, A. D., Kaczmarek, A., Krysko, O., Agostinis, P., & Vandenabeele, P. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3380 · Cited by 3,223
Car t cell immunotherapy for human cancer
June, C. H., O’Connor, R. S., Kawalekar, O. U., Ghassemi, S., & Milone, M. C. (2018) · Science · doi:10.1126/science.aar6711 · Cited by 3,207
Immunogenic cell death in cancer and infectious disease
Galluzzi, L., Buqué, A., Kepp, O., Zitvogel, L., & Kroemer, G. (2017) · Nature Reviews Immunology · doi:10.1038/nri.2016.107 · Cited by 3,119
Cancer immunotherapy: moving beyond current vaccines
Rosenberg, S. A., Yang, J. C., & Restifo, N. P. (2004) · Nature Medicine · doi:10.1038/nm1100 · Cited by 2,972
Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis
Menendez, J. A., & Lupu, R. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2222 · Cited by 2,941
An immunogenic personal neoantigen vaccine for patients with melanoma
Ott, P. A., Hu, Z., Keskin, D. B., Shukla, S. A., Sun, J., Bozym, D. J., Zhang, W., Luoma, A., Giobbie-Hurder, A., Peter, L., et al. (2017) · Nature · doi:10.1038/nature22991 · Cited by 2,936
Walport, M. J. (2001) · New England Journal of Medicine · doi:10.1056/nejm200104053441406 · Cited by 2,927
Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy
Hotchkiss, R. S., Monneret, G., & Payen, D. (2013) · Nature Reviews Immunology · doi:10.1038/nri3552 · Cited by 2,772
Adoptive cell transfer as personalized immunotherapy for human cancer
Rosenberg, S. A., & Restifo, N. P. (2015) · Science · doi:10.1126/science.aaa4967 · Cited by 2,506
Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancer
Sahin, U., Derhovanessian, E., Miller, M., Kloke, B.-P., Simon, P., Löwer, M., Bukur, V., Tadmor, A. D., Luxemburger, U., Schrörs, B., et al. (2017) · Nature · doi:10.1038/nature23003 · Cited by 2,488
Tumour heterogeneity and cancer cell plasticity
Meacham, C. E., & Morrison, S. J. (2013) · Nature · doi:10.1038/nature12624 · Cited by 2,446
Erythrocyte membrane-camouflaged polymeric nanoparticles as a biomimetic delivery platform
Hu, C.-M. J., Zhang, L., Aryal, S., Cheung, C., Fang, R. H., & Zhang, L. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1106634108 · Cited by 2,433
Self-citationChimeric Antigen Receptor Therapy
June, C. H., & Sadelain, M. (2018) · New England Journal of Medicine · doi:10.1056/nejmra1706169 · Cited by 2,331
Regulation of Adaptive Immunity by the Innate Immune System
Iwasaki, A., & Medzhitov, R. (2010) · Science · doi:10.1126/science.1183021 · Cited by 2,157
Vaccine delivery: a matter of size, geometry, kinetics and molecular patterns
Bachmann, M. F., & Jennings, G. T. (2010) · Nature Reviews Immunology · doi:10.1038/nri2868 · Cited by 2,106
The Path to Personalized Medicine
Hamburg, M. A., & Collins, F. S. (2010) · New England Journal of Medicine · doi:10.1056/nejmp1006304 · Cited by 1,970
Outer-membrane vesicles from Gram-negative bacteria: biogenesis and functions
Schwechheimer, C., & Kuehn, M. J. (2015) · Nature Reviews Microbiology · doi:10.1038/nrmicro3525 · Cited by 1,922
Cell Membrane Coating Nanotechnology
Fang, R. H., Kroll, A. V., Gao, W., & Zhang, L. (2018) · Advanced Materials · doi:10.1002/adma.201706759 · Cited by 1,885
Self-citationNanoparticle biointerfacing by platelet membrane cloaking
Hu, C.-M. J., Fang, R. H., Wang, K.-C., Luk, B. T., Thamphiwatana, S., Dehaini, D., Nguyen, P., Angsantikul, P., Wen, C. H., Kroll, A. V., et al. (2015) · Nature · doi:10.1038/nature15373 · Cited by 1,789
Self-citationInactivation of Antibiotics and the Dissemination of Resistance Genes
Davies, J. (1994) · Science · doi:10.1126/science.8153624 · Cited by 1,730
Clonal selection and learning in the antibody system
Rajewsky, K. (1996) · Nature · doi:10.1038/381751a0 · Cited by 1,709
Adoptive cell transfer: a clinical path to effective cancer immunotherapy
Rosenberg, S. A., Restifo, N. P., Yang, J. C., Morgan, R. A., & Dudley, M. E. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2355 · Cited by 1,659
Cross-presentation by dendritic cells
Joffre, O. P., Segura, E., Savina, A., & Amigorena, S. (2012) · Nature Reviews Immunology · doi:10.1038/nri3254 · Cited by 1,637
Cytokines in cancer pathogenesis and cancer therapy
Dranoff, G. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1252 · Cited by 1,573
Novel adeno-associated viruses from rhesus monkeys as vectors for human gene therapy
Gao, G.-P., Alvira, M. R., Wang, L., Calcedo, R., Johnston, J., & Wilson, J. M. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.182412299 · Cited by 1,520
Cancer Cell Membrane-Coated Nanoparticles for Anticancer Vaccination and Drug Delivery
Fang, R. H., Hu, C.-M. J., Luk, B. T., Gao, W., Copp, J. A., Tai, Y., O’Connor, D. E., & Zhang, L. (2014) · Nano Letters · doi:10.1021/nl500618u · Cited by 1,501
Self-citationPlatforms for antibiotic discovery
Lewis, K. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd3975 · Cited by 1,445
Russell, S. J., Peng, K.-W., & Bell, J. C. (2012) · Nature Biotechnology · doi:10.1038/nbt.2287 · Cited by 1,428
Resistance to Antibiotics: Are We in the Post-Antibiotic Era?
Alanis, A. J. (2005) · Archives of Medical Research · doi:10.1016/j.arcmed.2005.06.009 · Cited by 1,417
Anti-virulence strategies to combat bacteria-mediated disease
Rasko, D. A., & Sperandio, V. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3013 · Cited by 1,373
Exploiting lymphatic transport and complement activation in nanoparticle vaccines
Reddy, S. T., van der Vlies, A. J., Simeoni, E., Angeli, V., Randolph, G. J., O'Neil, C. P., Lee, L. K., Swartz, M. A., & Hubbell, J. A. (2007) · Nature Biotechnology · doi:10.1038/nbt1332 · Cited by 1,350
The plasticity of aging: insights from long-lived mutants
Kenyon, C. (2005) · Cell · doi:10.1016/j.cell.2005.02.002 · Cited by 1,338
Nanoparticles target distinct dendritic cell populations according to their size
Manolova, V., Flace, A., Bauer, M., Schwarz, K., Saudan, P., & Bachmann, M. F. (2008) · European Journal of Immunology · doi:10.1002/eji.200737984 · Cited by 1,289
A dendritic cell vaccine increases the breadth and diversity of melanoma neoantigen-specific T cells
Carreno, B. M., Magrini, V., Becker-Hapak, M., Kaabinejadian, S., Hundal, J., Petti, A. A., Ly, A., Lie, W.-R., Hildebrand, W. H., Mardis, E. R., et al. (2015) · Science · doi:10.1126/science.aaa3828 · Cited by 1,285
Bio-inspired, bioengineered and biomimetic drug delivery carriers
Yoo, J.-W., Irvine, D. J., Discher, D. E., & Mitragotri, S. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3499 · Cited by 1,236
Biologically active sphingolipids in cancer pathogenesis and treatment
Ogretmen, B., & Hannun, Y. A. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1411 · Cited by 1,213
Dendritic cells as therapeutic vaccines against cancer
Banchereau, J., & Palucka, A. K. (2005) · Nature Reviews Immunology · doi:10.1038/nri1592 · Cited by 1,204
Dendritic cells in a mature age
Reis e Sousa, C. (2006) · Nature Reviews Immunology · doi:10.1038/nri1845 · Cited by 1,195
Antigen-Presenting Function of the Macrophage
Unanue, E. R. (1984) · Annual Review of Immunology · doi:10.1146/annurev.iy.02.040184.002143 · Cited by 1,171
Parodi, A., Quattrocchi, N., van de Ven, A. L., Chiappini, C., Evangelopoulos, M., Martinez, J. O., Brown, B. S., Khaled, S. Z., Yazdi, I. K., Enzo, M. V., et al. (2013) · Nature Nanotechnology · doi:10.1038/nnano.2012.212 · Cited by 1,168
Platelet-collagen interaction: is GPVI the central receptor?
Nieswandt, B., & Watson, S. P. (2003) · Blood · doi:10.1182/blood-2002-12-3882 · Cited by 1,150
Engineered T cells: the promise and challenges of cancer immunotherapy
Fesnak, A. D., June, C. H., & Levine, B. L. (2016) · Nature Reviews Cancer · doi:10.1038/nrc.2016.97 · Cited by 1,074
Designer vaccine nanodiscs for personalized cancer immunotherapy
Kuai, R., Ochyl, L. J., Bahjat, K. S., Schwendeman, A., & Moon, J. J. (2017) · Nature Materials · doi:10.1038/nmat4822 · Cited by 1,056
Monitoring immune-checkpoint blockade: response evaluation and biomarker development
Nishino, M., Ramaiya, N. H., Hatabu, H., & Hodi, F. S. (2017) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2017.88 · Cited by 1,023
Vaccine adjuvants: Current state and future trends
Petrovsky, N., & Aguilar, J. C. (2004) · Immunology & Cell Biology · doi:10.1111/j.0818-9641.2004.01272.x · Cited by 1,005
A STING-activating nanovaccine for cancer immunotherapy
Luo, M., Wang, H., Wang, Z., Cai, H., Lu, Z., Li, Y., Du, M., Huang, G., Wang, C., Chen, X., et al. (2017) · Nature Nanotechnology · doi:10.1038/nnano.2017.52 · Cited by 900
Chen, Z., Zhao, P., Luo, Z., Zheng, M., Tian, H., Gong, P., Gao, G., Pan, H., Liu, L., Ma, A., et al. (2016) · ACS Nano · doi:10.1021/acsnano.6b04695 · Cited by 895
Virus-like particles in vaccine development
Roldão, A., Mellado, M. C. M., Castilho, L. R., Carrondo, M. J., & Alves, P. M. (2010) · Expert Review of Vaccines · doi:10.1586/erv.10.115 · Cited by 845
Host-directed therapies for bacterial and viral infections
Kaufmann, S. H. E., Dorhoi, A., Hotchkiss, R. S., & Bartenschlager, R. (2018) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2017.162 · Cited by 831
Stojdl, D. F., Lichty, B., Knowles, S., Marius, R., Atkins, H., Sonenberg, N., & Bell, J. C. (2000) · Nature Medicine · doi:10.1038/77558 · Cited by 815
Different drugs for bad bugs: antivirulence strategies in the age of antibiotic resistance
Dickey, S. W., Cheung, G. Y. C., & Otto, M. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2017.23 · Cited by 799
The biology and future prospects of antivirulence therapies
Cegelski, L., Marshall, G. R., Eldridge, G. R., & Hultgren, S. J. (2008) · Nature Reviews Microbiology · doi:10.1038/nrmicro1818 · Cited by 788
The who, how and where of antigen presentation to B cells
Batista, F. D., & Harwood, N. E. (2009) · Nature Reviews Immunology · doi:10.1038/nri2454 · Cited by 775
Erythrocyte–Platelet Hybrid Membrane Coating for Enhanced Nanoparticle Functionalization
Dehaini, D., Wei, X., Fang, R. H., Masson, S., Angsantikul, P., Luk, B. T., Zhang, Y., Ying, M., Jiang, Y., Kroll, A. V., et al. (2017) · Advanced Materials · doi:10.1002/adma.201606209 · Cited by 769
Self-citationEngineering adeno-associated viruses for clinical gene therapy
Kotterman, M. A., & Schaffer, D. V. (2014) · Nature Reviews Genetics · doi:10.1038/nrg3742 · Cited by 761
A biomimetic nanosponge that absorbs pore-forming toxins
Hu, C.-M. J., Fang, R. H., Copp, J., Luk, B. T., & Zhang, L. (2013) · Nature Nanotechnology · doi:10.1038/nnano.2013.54 · Cited by 751
Self-citationVaccines for established cancer: overcoming the challenges posed by immune evasion
van der Burg, S. H., Arens, R., Ossendorp, F., van Hall, T., & Melief, C. J. M. (2016) · Nature Reviews Cancer · doi:10.1038/nrc.2016.16 · Cited by 709
Yang, R., Xu, J., Xu, L., Sun, X., Chen, Q., Zhao, Y., Peng, R., & Liu, Z. (2018) · ACS Nano · doi:10.1021/acsnano.7b09041 · Cited by 698
Engineering targeted viral vectors for gene therapy
Waehler, R., Russell, S. J., & Curiel, D. T. (2007) · Nature Reviews Genetics · doi:10.1038/nrg2141 · Cited by 687
Modelling breast cancer: one size does not fit all
Vargo-Gogola, T., & Rosen, J. M. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2193 · Cited by 679
Self-medication: A current challenge
Bennadi, D. (2014) · Journal of Basic and Clinical Pharmacy · doi:10.4103/0976-0105.128253 · Cited by 674
Shae, D., Becker, K. W., Christov, P., Yun, D. S., Lytton-Jean, A. K. R., Sevimli, S., Ascano, M., Kelley, M., Johnson, D. B., Balko, J. M., et al. (2019) · Nature Nanotechnology · doi:10.1038/s41565-018-0342-5 · Cited by 668
The multifaceted role of CD4+ T cells in CD8+ T cell memory
Laidlaw, B. J., Craft, J. E., & Kaech, S. M. (2016) · Nature Reviews Immunology · doi:10.1038/nri.2015.10 · Cited by 657
The mannose receptor is a pattern recognition receptor involved in host defense
Stahl, P. D., & Ezekowitz, R. A. B. (1998) · Current Opinion in Immunology · doi:10.1016/s0952-7915(98)80031-9 · Cited by 638
Dynamics of CD8+ T cell priming by dendritic cells in intact lymph nodes
Bousso, P., & Robey, E. (2003) · Nature Immunology · doi:10.1038/ni928 · Cited by 625
Bacterial outer membrane vesicles suppress tumor by interferon-γ-mediated antitumor response
Kim, O. Y., Park, H. T., Dinh, N. T. H., Choi, S. J., Lee, J., Kim, J. H., Lee, S.-W., & Gho, Y. S. (2017) · Nature Communications · doi:10.1038/s41467-017-00729-8 · Cited by 616
Jackson, H. J., Rafiq, S., & Brentjens, R. J. (2016) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2016.36 · Cited by 613
Viruses: Making Friends with Old Foes
Douglas, T., & Young, M. (2006) · Science · doi:10.1126/science.1123223 · Cited by 601
Pathogen recognition in the innate immune response
Kumar, H., Kawai, T., & Akira, S. (2009) · Biochemical Journal · doi:10.1042/bj20090272 · Cited by 590
Going viral with cancer immunotherapy
Lichty, B. D., Breitbach, C. J., Stojdl, D. F., & Bell, J. C. (2014) · Nature Reviews Cancer · doi:10.1038/nrc3770 · Cited by 581
Moon, J. J., Suh, H., Bershteyn, A., Stephan, M. T., Liu, H., Huang, B., Sohail, M., Luo, S., Ho Um, S., Khant, H., et al. (2011) · Nature Materials · doi:10.1038/nmat2960 · Cited by 564
Thamphiwatana, S., Angsantikul, P., Escajadillo, T., Zhang, Q., Olson, J., Luk, B. T., Zhang, S., Fang, R. H., Gao, W., Nizet, V., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1714267114 · Cited by 563
Self-citationCancer Cell Membrane‐Coated Upconversion Nanoprobes for Highly Specific Tumor Imaging
Rao, L., Bu, L., Cai, B., Xu, J., Li, A., Zhang, W., Sun, Z., Guo, S., Liu, W., Wang, T., et al. (2016) · Advanced Materials · doi:10.1002/adma.201506086 · Cited by 530
In situ activation of platelets with checkpoint inhibitors for post-surgical cancer immunotherapy
Wang, C., Sun, W., Ye, Y., Hu, Q., Bomba, H. N., & Gu, Z. (2017) · Nature Biomedical Engineering · doi:10.1038/s41551-016-0011 · Cited by 526
A multifunctional core–shell nanoparticle for dendritic cell-based cancer immunotherapy
Cho, N.-H., Cheong, T.-C., Min, J. H., Wu, J. H., Lee, S. J., Kim, D., Yang, J.-S., Kim, S., Kim, Y. K., & Seong, S.-Y. (2011) · Nature Nanotechnology · doi:10.1038/nnano.2011.149 · Cited by 514
Modulating Antibacterial Immunity via Bacterial Membrane-Coated Nanoparticles
Gao, W., Fang, R. H., Thamphiwatana, S., Luk, B. T., Li, J., Angsantikul, P., Zhang, Q., Hu, C.-M. J., & Zhang, L. (2015) · Nano Letters · doi:10.1021/nl504798g · Cited by 509
Self-citationNanoparticulate Delivery of Cancer Cell Membrane Elicits Multiantigenic Antitumor Immunity
Kroll, A. V., Fang, R. H., Jiang, Y., Zhou, J., Wei, X., Yu, C. L., Gao, J., Luk, B. T., Dehaini, D., Gao, W., et al. (2017) · Advanced Materials · doi:10.1002/adma.201703969 · Cited by 501
Self-citationHoshino, Y., Koide, H., Urakami, T., Kanazawa, H., Kodama, T., Oku, N., & Shea, K. J. (2010) · Journal of the American Chemical Society · doi:10.1021/ja102148f · Cited by 495
Atypical MHC class II-expressing antigen-presenting cells: can anything replace a dendritic cell?
Kambayashi, T., & Laufer, T. M. (2014) · Nature Reviews Immunology · doi:10.1038/nri3754 · Cited by 495
The impact of antibiotic use on resistance development and persistence
Barbosa, T. M., & Levy, S. B. (2000) · Drug Resistance Updates · doi:10.1054/drup.2000.0167 · Cited by 493
The interaction of bacterial pathogens with platelets
Fitzgerald, J. R., Foster, T. J., & Cox, D. (2006) · Nature Reviews Microbiology · doi:10.1038/nrmicro1425 · Cited by 489
In situ vaccination with cowpea mosaic virus nanoparticles suppresses metastatic cancer
Lizotte, P. H., Wen, A. M., Sheen, M. R., Fields, J., Rojanasopondist, P., Steinmetz, N. F., & Fiering, S. (2016) · Nature Nanotechnology · doi:10.1038/nnano.2015.292 · Cited by 485
Cell membrane-derived nanomaterials for biomedical applications
Fang, R. H., Jiang, Y., Fang, J. C., & Zhang, L. (2017) · Biomaterials · doi:10.1016/j.biomaterials.2017.02.041 · Cited by 468
Self-citationPetousis-Harris, H., Paynter, J., Morgan, J., Saxton, P., McArdle, B., Goodyear-Smith, F., & Black, S. (2017) · The Lancet · doi:10.1016/s0140-6736(17)31449-6 · Cited by 457
Personalized medicine: revolutionizing drug discovery and patient care
Ginsburg, G. (2001) · Trends in Biotechnology · doi:10.1016/s0167-7799(01)01814-5 · Cited by 456
Biomimetics—using nature to inspire human innovation
Bar-Cohen, Y. (2006) · Bioinspiration & Biomimetics · doi:10.1088/1748-3182/1/1/p01 · Cited by 430
Tam, H. H., Melo, M. B., Kang, M., Pelet, J. M., Ruda, V. M., Foley, M. H., Hu, J. K., Kumari, S., Crampton, J., Baldeon, A. D., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1606050113 · Cited by 425
Deng, G., Sun, Z., Li, S., Peng, X., Li, W., Zhou, L., Ma, Y., Gong, P., & Cai, L. (2018) · ACS Nano · doi:10.1021/acsnano.8b05292 · Cited by 416
Guo, Y., Wang, D., Song, Q., Wu, T., Zhuang, X., Bao, Y., Kong, M., Qi, Y., Tan, S., & Zhang, Z. (2015) · ACS Nano · doi:10.1021/acsnano.5b01042 · Cited by 413
Current Concepts of Antigen Cross-Presentation
Embgenbroich, M., & Burgdorf, S. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01643 · Cited by 397
A mucosal vaccine against Chlamydia trachomatis generates two waves of protective memory T cells
Stary, G., Olive, A., Radovic-Moreno, A. F., Gondek, D., Alvarez, D., Basto, P. A., Perro, M., Vrbanac, V. D., Tager, A. M., Shi, J., et al. (2015) · Science · doi:10.1126/science.aaa8205 · Cited by 379
Biointerfacing and Applications of Cell Membrane-Coated Nanoparticles
Kroll, A. V., Fang, R. H., & Zhang, L. (2017) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.6b00569 · Cited by 379
Self-citationElimination of established tumors with nanodisc-based combination chemoimmunotherapy
Kuai, R., Yuan, W., Son, S., Nam, J., Xu, Y., Fan, Y., Schwendeman, A., & Moon, J. J. (2018) · Science Advances · doi:10.1126/sciadv.aao1736 · Cited by 352
Nanoparticle approaches against bacterial infections
Gao, W., Thamphiwatana, S., Angsantikul, P., & Zhang, L. (2014) · WIREs Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1282 · Cited by 347
Self-citationLi, H., Li, Y., Jiao, J., & Hu, H.-M. (2011) · Nature Nanotechnology · doi:10.1038/nnano.2011.153 · Cited by 347
Artificial viruses: a nanotechnological approach to gene delivery
Mastrobattista, E., van der Aa, M. A. E. M., Hennink, W. E., & Crommelin, D. J. A. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd1960 · Cited by 346
Nanoparticle-detained toxins for safe and effective vaccination
Hu, C.-M. J., Fang, R. H., Luk, B. T., & Zhang, L. (2013) · Nature Nanotechnology · doi:10.1038/nnano.2013.254 · Cited by 342
Self-citationTargeting of tumor endothelium by RGD-grafted PLGA-nanoparticles loaded with Paclitaxel
Danhier, F., Vroman, B., Lecouturier, N., Crokart, N., Pourcelle, V., Freichels, H., Jérôme, C., Marchand-Brynaert, J., Feron, O., & Préat, V. (2009) · Journal of Controlled Release · doi:10.1016/j.jconrel.2009.08.011 · Cited by 335
An O2 Self‐Sufficient Biomimetic Nanoplatform for Highly Specific and Efficient Photodynamic Therapy
Cheng, H., Zhu, J., Li, S., Zeng, J., Lei, Q., Chen, K., Zhang, C., & Zhang, X. (2016) · Advanced Functional Materials · doi:10.1002/adfm.201603212 · Cited by 335
Wei, X., Ying, M., Dehaini, D., Su, Y., Kroll, A. V., Zhou, J., Gao, W., Fang, R. H., Chien, S., & Zhang, L. (2018) · ACS Nano · doi:10.1021/acsnano.7b07720 · Cited by 329
Self-citationRelease of Staphylococcus aureus extracellular vesicles and their application as a vaccine platform
Wang, X., Thompson, C. D., Weidenmaier, C., & Lee, J. C. (2018) · Nature Communications · doi:10.1038/s41467-018-03847-z · Cited by 326
CD40 and its ligand, an essential ligand-receptor pair for thymus-dependent B-cell activation
Noelle, R. J., Ledbetter, J. A., & Aruffo, A. A. (1992) · Immunology Today · doi:10.1016/0167-5699(92)90068-i · Cited by 324
Virus-like particles: flexible platforms for vaccine development
Chackerian, B. (2007) · Expert Review of Vaccines · doi:10.1586/14760584.6.3.381 · Cited by 321
Hu, Q., Sun, W., Wang, J., Ruan, H., Zhang, X., Ye, Y., Shen, S., Wang, C., Lu, W., Cheng, K., et al. (2018) · Nature Biomedical Engineering · doi:10.1038/s41551-018-0310-2 · Cited by 310
Erythrocyte‐Inspired Delivery Systems
Hu, C. J., Fang, R. H., & Zhang, L. (2012) · Advanced Healthcare Materials · doi:10.1002/adhm.201200138 · Cited by 308
Self-citationRole of sustained antigen release from nanoparticle vaccines in shaping the T cell memory phenotype
Demento, S. L., Cui, W., Criscione, J. M., Stern, E., Tulipan, J., Kaech, S. M., & Fahmy, T. M. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2012.03.041 · Cited by 304
Platelets in defense against bacterial pathogens
Yeaman, M. R. (2010) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-009-0210-4 · Cited by 303
Delivery of foreign antigens by engineered outer membrane vesicle vaccines
Chen, D. J., Osterrieder, N., Metzger, S. M., Buckles, E., Doody, A. M., DeLisa, M. P., & Putnam, D. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0805532107 · Cited by 302
Lipid-insertion enables targeting functionalization of erythrocyte membrane-cloaked nanoparticles
Fang, R. H., Hu, C.-M. J., Chen, K. N. H., Luk, B. T., Carpenter, C. W., Gao, W., Li, S., Zhang, D.-E., Lu, W., & Zhang, L. (2013) · Nanoscale · doi:10.1039/c3nr03064d · Cited by 302
Self-citationShi, G.-N., Zhang, C.-N., Xu, R., Niu, J.-F., Song, H.-J., Zhang, X.-Y., Wang, W.-W., Wang, Y.-M., Li, C., Wei, X.-Q., et al. (2017) · Biomaterials · doi:10.1016/j.biomaterials.2016.10.047 · Cited by 299
Clearance of pathological antibodies using biomimetic nanoparticles
Copp, J. A., Fang, R. H., Luk, B. T., Hu, C.-M. J., Gao, W., Zhang, K., & Zhang, L. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1412420111 · Cited by 296
Self-citationBioengineering bacterial outer membrane vesicles as vaccine platform
Gerritzen, M. J. H., Martens, D. E., Wijffels, R. H., van der Pol, L., & Stork, M. (2017) · Biotechnology Advances · doi:10.1016/j.biotechadv.2017.05.003 · Cited by 290
PD‐1 Blockade Cellular Vesicles for Cancer Immunotherapy
Zhang, X., Wang, C., Wang, J., Hu, Q., Langworthy, B., Ye, Y., Sun, W., Lin, J., Wang, T., Fine, J., et al. (2018) · Advanced Materials · doi:10.1002/adma.201707112 · Cited by 290
Cancer immunology—analysis of host and tumor factors for personalized medicine
Ogino, S., Galon, J., Fuchs, C. S., & Dranoff, G. (2011) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2011.122 · Cited by 284
Glinsky, V. V., Glinsky, G. V., Glinskii, O. V., Huxley, V. H., Turk, J. R., Mossine, V. V., Deutscher, S. L., Pienta, K. J., & Quinn, T. P. (2004) · Urologic Oncology: Seminars and Original Investigations · doi:10.1016/j.urolonc.2003.12.009 · Cited by 266
Song, Q., Yin, Y., Shang, L., Wu, T., Zhang, D., Kong, M., Zhao, Y., He, Y., Tan, S., Guo, Y., et al. (2017) · Nano Letters · doi:10.1021/acs.nanolett.7b03186 · Cited by 254
Chai, Z., Hu, X., Wei, X., Zhan, C., Lu, L., Jiang, K., Su, B., Ruan, H., Ran, D., Fang, R. H., et al. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.08.027 · Cited by 253
Self-citationLuk, B. T., Fang, R. H., Hu, C.-M. J., Copp, J. A., Thamphiwatana, S., Dehaini, D., Gao, W., Zhang, K., Li, S., & Zhang, L. (2016) · Theranostics · doi:10.7150/thno.14471 · Cited by 247
Self-citationUnleashing the therapeutic potential of NOD-like receptors
Geddes, K., Magalhães, J. G., & Girardin, S. E. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2783 · Cited by 232
Engineering PD-1-Presenting Platelets for Cancer Immunotherapy
Zhang, X., Wang, J., Chen, Z., Hu, Q., Wang, C., Yan, J., Dotti, G., Huang, P., & Gu, Z. (2018) · Nano Letters · doi:10.1021/acs.nanolett.8b02321 · Cited by 232
Biodegradable STING agonist nanoparticles for enhanced cancer immunotherapy
Wilson, D. R., Sen, R., Sunshine, J. C., Pardoll, D. M., Green, J. J., & Kim, Y. J. (2018) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2017.10.013 · Cited by 220
Immunogenic Cell Death Amplified by Co-localized Adjuvant Delivery for Cancer Immunotherapy
Fan, Y., Kuai, R., Xu, Y., Ochyl, L. J., Irvine, D. J., & Moon, J. J. (2017) · Nano Letters · doi:10.1021/acs.nanolett.7b03218 · Cited by 220
Wei, X., Gao, J., Fang, R. H., Luk, B. T., Kroll, A. V., Dehaini, D., Zhou, J., Kim, H. W., Gao, W., Lu, W., et al. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2016.10.003 · Cited by 218
Self-citationTowards efficient cancer immunotherapy: advances in developing artificial antigen-presenting cells
Eggermont, L. J., Paulis, L. E., Tel, J., & Figdor, C. G. (2014) · Trends in Biotechnology · doi:10.1016/j.tibtech.2014.06.007 · Cited by 217
Zhang, Q., Wei, W., Wang, P., Zuo, L., Li, F., Xu, J., Xi, X., Gao, X., Ma, G., & Xie, H.-Y. (2017) · ACS Nano · doi:10.1021/acsnano.7b04955 · Cited by 210
Fontana, F., Shahbazi, M., Liu, D., Zhang, H., Mäkilä, E., Salonen, J., Hirvonen, J. T., & Santos, H. A. (2017) · Advanced Materials · doi:10.1002/adma.201603239 · Cited by 193
Outer Membrane Vesicles: Current Status and Future Direction of These Novel Vaccine Adjuvants
Tan, K., Li, R., Huang, X., & Liu, Q. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.00783 · Cited by 191
Yu, G., Rao, L., Wu, H., Yang, L., Bu, L., Deng, W., Wu, L., Nan, X., Zhang, W., Zhao, X., et al. (2018) · Advanced Functional Materials · doi:10.1002/adfm.201801389 · Cited by 189
Glinsky, V. V., Glinsky, G. V., Glinskii, O. V., Huxley, V. H., Turk, J. R., Mossine, V. V., Deutscher, S. L., Pienta, K. J., & Quinn, T. P. (2003) · PubMed · Cited by 186
Li, A. V., Moon, J. J., Abraham, W., Suh, H., Elkhader, J., Seidman, M. A., Yen, M., Im, E.-J., Foley, M. H., Barouch, D. H., et al. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3006516 · Cited by 186
Meyer, R. A., Sunshine, J. C., Perica, K., Kosmides, A. K., Aje, K., Schneck, J. P., & Green, J. J. (2015) · Small · doi:10.1002/smll.201402369 · Cited by 183
A D‐Peptide Ligand of Nicotine Acetylcholine Receptors for Brain‐Targeted Drug Delivery
Wei, X., Zhan, C., Shen, Q., Fu, W., Xie, C., Gao, J., Peng, C., Zheng, P., & Lu, W. (2015) · Angewandte Chemie International Edition · doi:10.1002/anie.201411226 · Cited by 181
Angsantikul, P., Thamphiwatana, S., Zhang, Q., Spiekermann, K., Zhuang, J., Fang, R. H., Gao, W., Obonyo, M., & Zhang, L. (2018) · Advanced Therapeutics · doi:10.1002/adtp.201800016 · Cited by 180
Self-citationNanoparticles disguised as red blood cells to evade the immune system
Fang, R. H., Hu, C.-M. J., & Zhang, L. (2012) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2012.661710 · Cited by 174
Self-citationBiomimetic strategies for targeted nanoparticle delivery
Dehaini, D., Fang, R. H., & Zhang, L. (2016) · Bioengineering & Translational Medicine · doi:10.1002/btm2.10004 · Cited by 168
Self-citationControl of cross‐presentation during dendritic cell maturation
Gil‐Torregrosa, B. C., Lennon‐Duménil, A. M., Kessler, B., Guermonprez, P., Ploegh, H. L., Fruci, D., Endert, P. V., & Amigorena, S. (2004) · European Journal of Immunology · doi:10.1002/eji.200324508 · Cited by 167
Whole Cell Vaccines—Past Progress and Future Strategies
Keenan, B. P., & Jaffee, E. M. (2012) · Seminars in Oncology · doi:10.1053/j.seminoncol.2012.02.007 · Cited by 165
The Sociomicrobiology of Antivirulence Drug Resistance: a Proof of Concept
Mellbye, B., & Schuster, M. (2011) · mBio · doi:10.1128/mbio.00131-11 · Cited by 164
Micelle‐Based Brain‐Targeted Drug Delivery Enabled by a Nicotine Acetylcholine Receptor Ligand
Zhan, C., Li, B., Hu, L., Wei, X., Feng, L., Fu, W., & Lu, W. (2011) · Angewandte Chemie International Edition · doi:10.1002/anie.201100875 · Cited by 153
A Facile Approach to Functionalize Cell Membrane-Coated Nanoparticles
Zhou, H., Fan, Z., Lemons, P. K., & Cheng, H. (2016) · Theranostics · doi:10.7150/thno.15095 · Cited by 152
Hickey, J. W., Vicente, F. P., Howard, G. P., Mao, H., & Schneck, J. P. (2017) · Nano Letters · doi:10.1021/acs.nanolett.7b03734 · Cited by 152
Overcoming implementation challenges of personalized cancer therapy
Meric‐Bernstam, F., & Mills, G. B. (2012) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2012.127 · Cited by 150
Nanoscale artificial antigen presenting cells for T cell immunotherapy
Perica, K., Medero, A. D. L., Durai, M., Chiu, Y., Bieler, J. G., Sibener, L. V., Niemöller, M., Assenmacher, M., Richter, A., Edidin, M. A., et al. (2013) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2013.06.015 · Cited by 149
Silva, J. M., Zupančič, E., Vandermeulen, G., Oliveira, V. G., Salgado, A., Videira, M., Gaspar, M. M., Graça, L., Véronique Préat, A., & Florindo, H. F. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.11.033 · Cited by 146
Next-generation precision antimicrobials: towards personalized treatment of infectious diseases
de la Fuente‐Núñez, C., Torres, M. D. T., Mojica, F. J. M., & Lu, T. K. (2017) · Current Opinion in Microbiology · doi:10.1016/j.mib.2017.05.014 · Cited by 145
Chen, Y., Chen, M., Zhang, Y., Lee, J. H., Escajadillo, T., Gong, H., Fang, R. H., Gao, W., Nizet, V., & Zhang, L. (2018) · Advanced Healthcare Materials · doi:10.1002/adhm.201701366 · Cited by 144
Self-citationEngineered nanoparticles mimicking cell membranes for toxin neutralization
Fang, R. H., Luk, B. T., Hu, C. J., & Zhang, L. (2015) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.04.001 · Cited by 141
Self-citationLiposome-based glioma targeted drug delivery enabled by stable peptide ligands
Wei, X., Gao, J., Zhan, C., Xie, C., Chai, Z., Ran, D., Man, Y. M., Zheng, P., & Lu, W. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.09.059 · Cited by 141
The immune checkpoint inhibitors: where are we now?
Webster, R. M. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4476 · Cited by 140
Outer membrane vesicles displaying engineered glycotopes elicit protective antibodies
Chen, L., Valentine, J. L., Huang, C., Endicott, C. E., Moeller, T. D., Rasmussen, J. A., Fletcher, J. R., Boll, J. M., Rosenthal, J. A., Dobruchowska, J. M., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1518311113 · Cited by 140
Potentiating Cancer Immunotherapy Using Papaya Mosaic Virus-Derived Nanoparticles
Lebel, M., Chartrand, K., Tarrab, E., Savard, P. E., Leclerc, D., & Lamarre, A. (2016) · Nano Letters · doi:10.1021/acs.nanolett.5b04877 · Cited by 138
Nanoparticle-Mediated Cytoplasmic Delivery of Proteins To Target Cellular Machinery
Bale, S. S., Kwon, S., Shah, D. A., Banerjee, A., Dordick, J. S., & Kane, R. S. (2010) · ACS Nano · doi:10.1021/nn901586e · Cited by 133
Treatment of Canine Oral Melanoma with Nanotechnology-Based Immunotherapy and Radiation
Hoopes, P. J., Wagner, R. J., Duval, K. E. A., Kang, K., Gladstone, D. J., Moodie, K. L., Crary-Burney, M., Arias‐Pulido, H., Veliz, F. A., Steinmetz, N. F., et al. (2018) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.8b00126 · Cited by 127
Wang, F., Fang, R. H., Luk, B. T., Hu, C. J., Thamphiwatana, S., Dehaini, D., Angsantikul, P., Kroll, A. V., Pang, Z., Gao, W., et al. (2016) · Advanced Functional Materials · doi:10.1002/adfm.201505231 · Cited by 126
Self-citationNanoparticle-Based Manipulation of Antigen-Presenting Cells for Cancer Immunotherapy
Fang, R. H., Kroll, A. V., & Zhang, L. (2015) · Small · doi:10.1002/smll.201501284 · Cited by 124
Self-citationBiomimetic Nanoemulsions for Oxygen Delivery In Vivo
Zhuang, J., Man, Y. M., Spiekermann, K., Holay, M., Zhang, Y., Chen, F., Gong, H., Lee, J. H., Gao, W., Fang, R. H., et al. (2018) · Advanced Materials · doi:10.1002/adma.201804693 · Cited by 124
Self-citationPrasad, S., Cody, V., Saucier-Sawyer, J. K., Saltzman, W. M., Sasaki, C. T., Edelson, R. L., Birchall, M., & Hanlon, D. J. (2010) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2010.07.002 · Cited by 122
PEGylated tumor cell membrane vesicles as a new vaccine platform for cancer immunotherapy
Ochyl, L. J., Bazzill, J. D., Park, C., Xu, Y., Kuai, R., & Moon, J. J. (2018) · Biomaterials · doi:10.1016/j.biomaterials.2018.08.016 · Cited by 121
In Situ Capture of Bacterial Toxins for Antivirulence Vaccination
Wei, X., Gao, J., Wang, F., Man, Y. M., Angsantikul, P., Kroll, A. V., Zhou, J., Gao, W., Lu, W., Fang, R. H., et al. (2017) · Advanced Materials · doi:10.1002/adma.201701644 · Cited by 118
Self-citationIn Situ Vaccination with Cowpea vs Tobacco Mosaic Virus against Melanoma
Murray, A. A., Wang, C., Fiering, S., & Steinmetz, N. F. (2018) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.8b00316 · Cited by 113
Shukla, S., Myers, J., Woods, S. E., Gong, X., Czapar, A. E., Commandeur, U., Huang, A. Y.-C., Levine, A. D., & Steinmetz, N. F. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2016.12.030 · Cited by 112
Polymer nanocarriers protecting active enzyme cargo against proteolysis
Dziubla, T. D., Karim, A., & Muzykantov, V. R. (2004) · Journal of Controlled Release · doi:10.1016/j.jconrel.2004.10.017 · Cited by 111
Design of Synthetic Polymer Nanoparticles that Capture and Neutralize a Toxic Peptide
Hoshino, Y., Urakami, T., Kodama, T., Koide, H., Oku, N., Okahata, Y., & Shea, K. J. (2009) · Small · doi:10.1002/smll.200900186 · Cited by 111
Umamaheshwari, R. B., & Jain, N. K. (2003) · Journal of drug targeting · doi:10.1080/10611860310001647771 · Cited by 110
Li, S., Xie, B., Cheng, H. B., Li, C., Zhang, M., Qiu, W., Liu, W., Wang, X., & Zhang, X. (2017) · Biomaterials · doi:10.1016/j.biomaterials.2017.10.021 · Cited by 109
Lin, L. C. W., Chattopadhyay, S., Lin, J., & Hu, C. J. (2018) · Advanced Healthcare Materials · doi:10.1002/adhm.201701395 · Cited by 109
Biomimetic Nanoparticle Vaccines for Cancer Therapy
Kroll, A. V., Jiang, Y., Zhou, J., Holay, M., Fang, R. H., & Zhang, L. (2018) · Advanced Biosystems · doi:10.1002/adbi.201800219 · Cited by 108
Self-citationNirthanan, S., Charpantier, E., Gopalakrishnakone, P., Gwee, M. C. E., Khoo, H., Cheah, L. S., Bertrand, D., & Kini, R. M. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m111152200 · Cited by 104
Lee, K. L., Murray, A. A., Le, D. H. T., Sheen, M. R., Shukla, S., Commandeur, U., Fiering, S., & Steinmetz, N. F. (2017) · Nano Letters · doi:10.1021/acs.nanolett.7b00107 · Cited by 102
Single cell analysis of human tissues and solid tumors with mass cytometry
Leelatian, N., Doxie, D. B., Greenplate, A. R., Mobley, B. C., Lehman, J. M., Sinnaeve, J., Kauffmann, R. M., Werkhaven, J. A., Mistry, A. M., Weaver, K. D., et al. (2016) · Cytometry Part B Clinical Cytometry · doi:10.1002/cyto.b.21481 · Cited by 102
Stevenson, T. C., Cywes‐Bentley, C., Moeller, T. D., Weyant, K. B., Putnam, D. A., Chang, Y., Jones, B. D., Pier, G. B., & DeLisa, M. P. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1718341115 · Cited by 101
A review of RGD-functionalized nonviral gene delivery vectors for cancer therapy
Park, J. Y., Singha, K., Son, S., Kim, J., Namgung, R., Yun, C.-O., & Kim, W.-J. (2012) · Cancer Gene Therapy · doi:10.1038/cgt.2012.64 · Cited by 100
Nanoparticle-Based Modulation of the Immune System
Fang, R. H., & Zhang, L. (2016) · Annual Review of Chemical and Biomolecular Engineering · doi:10.1146/annurev-chembioeng-080615-034446 · Cited by 99
Self-citationKang, T., Huang, Y., Zhu, Q., Cheng, H., Pei, Y., Feng, J., Xu, M., Jiang, G., Song, Q., Jiang, T., et al. (2018) · Biomaterials · doi:10.1016/j.biomaterials.2018.02.033 · Cited by 99
Fischer, N. O., Rasley, A., Corzett, M., Hwang, M. H., Hoeprich, P. D., & Blanchette, C. (2013) · Journal of the American Chemical Society · doi:10.1021/ja3063293 · Cited by 96
Coating nanofiber scaffolds with beta cell membrane to promote cell proliferation and function
Chen, W., Zhang, Q., Luk, B. T., Fang, R. H., Liu, Y., Gao, W., & Zhang, L. (2016) · Nanoscale · doi:10.1039/c6nr00535g · Cited by 96
Self-citationSolbrig, C., Saucier-Sawyer, J. K., Cody, V., Saltzman, W. M., & Hanlon, D. J. (2007) · Molecular Pharmaceutics · doi:10.1021/mp060107e · Cited by 94
Remote‐Loaded Platelet Vesicles for Disease‐Targeted Delivery of Therapeutics
Man, Y. M., Zhuang, J., Wei, X., Zhang, X., Zhang, Y., Jiang, Y., Dehaini, D., Chen, M., Gu, S., Gao, W., et al. (2018) · Advanced Functional Materials · doi:10.1002/adfm.201801032 · Cited by 88
Self-citationPatel, R. B., Czapar, A. E., Fiering, S., Oleinick, N. L., & Steinmetz, N. F. (2018) · ACS Omega · doi:10.1021/acsomega.8b00227 · Cited by 82
Nanoparticle-based vaccine for mucosal protection against Shigella flexneri in mice
Camacho, A. I., Irache, J. M., de Souza, J., Sánchez-Gómez, S., & Gamazo, C. (2013) · Vaccine · doi:10.1016/j.vaccine.2013.05.020 · Cited by 79
Single Cell Analysis of Human Tissues and Solid Tumors with Mass Cytometry
Leelatian, N., Doxie, D. B., Greenplate, A. R., Mobley, B. C., Lehman, J. M., Sinnaeve, J., Kauffmann, R. M., Werkhaven, J. A., Mistry, A. M., Weaver, K. D., et al. (2017) · Cytometry Part B Clinical Cytometry · doi:10.1002/cyto.b.21542 · Cited by 78
Nanoparticles-based multi-adjuvant whole cell tumor vaccine for cancer immunotherapy
Liu, S., Wei, W., Yue, H., Ni, D., Yue, Z., Wang, S., Fu, Q., Wang, Y., Ma, G., & Su, Z. G. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.07.020 · Cited by 75
Zhang, X., Yang, F., Zou, J., Wu, W., Jing, H., Gou, Q., Li, H., Gu, J., Zou, Q., & Zhang, J. (2018) · Vaccine · doi:10.1016/j.vaccine.2018.01.034 · Cited by 75
Jobsri, J., Allen, A., Rajagopal, D., Shipton, M. J., Kanyuka, K., Lomonossoff, G. P., Ottensmeier, C. H. H., Diebold, S. S., Stevenson, F. K., & Savelyeva, N. (2015) · PLoS ONE · doi:10.1371/journal.pone.0118096 · Cited by 71
Cited by
Targeting drugs to tumours using cell membrane-coated nanoparticles
Fang, R. H., Gao, W., & Zhang, L. (2023) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-022-00699-x · Cited by 980
Self-citationRecent Advances in Hyperthermia Therapy‐Based Synergistic Immunotherapy
Chang, M., Hou, Z., Wang, M., Li, C., & Lin, J. (2021) · Advanced Materials · doi:10.1002/adma.202004788 · Cited by 450
Cell membrane coating integrity affects the internalization mechanism of biomimetic nanoparticles
Liu, L., Bai, X., Martikainen, M.-V., Kårlund, A., Roponen, M., Xu, W., Hu, G., Tasciotti, E., & Lehto, V.-P. (2021) · Nature Communications · doi:10.1038/s41467-021-26052-x · Cited by 440
Platelet membrane-camouflaged magnetic nanoparticles for ferroptosis-enhanced cancer immunotherapy
Jiang, Q., Wang, K., Zhang, X., Ouyang, B., Liu, H., Pang, Z., & Yang, W. (2020) · Small · doi:10.1002/smll.202001704 · Cited by 426
Semiconducting polymer nano-PROTACs for activatable photo-immunometabolic cancer therapy
Zhang, C., Zeng, Z., Cui, D., He, S., Jiang, Y., Li, J., Huang, J., & Pu, K. (2021) · Nature Communications · doi:10.1038/s41467-021-23194-w · Cited by 411
Metadata
- Authors
- Zhou, J., Kroll, A. V., Holay, M., Fang, R. H., & Zhang, L.
- Venue
- Advanced Materials
- Publisher
- Wiley
- Published
- 2019-06-17
- Volume
- 32
- Issue
- 13
- Pages
- e1901255-e1901255
- ISSN
- 0935-9648 (ISSN-L)
- 1521-4095
- OpenAlex
- W2952233665
- Cited by
- 328
- References
- 214
- FWCI
- 12.02
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.